tiprankstipranks
Trending News
More News >
NeoGenomics: Hold Rating Amid Mixed Performance and Uncertain MRD Pathway
PremiumRatingsNeoGenomics: Hold Rating Amid Mixed Performance and Uncertain MRD Pathway
2M ago
NeoGenomics price target lowered to $10 from $17 at Morgan Stanley
Premium
The Fly
NeoGenomics price target lowered to $10 from $17 at Morgan Stanley
2M ago
NeoGenomics price target lowered to $12 from $17 at TD Cowen
Premium
The Fly
NeoGenomics price target lowered to $12 from $17 at TD Cowen
2M ago
NeoGenomics Reports Strong Q1 2025 Earnings Growth
PremiumCompany AnnouncementsNeoGenomics Reports Strong Q1 2025 Earnings Growth
2M ago
Optimistic Buy Rating for NeoGenomics Amid CEO Transition and Growth Potential
Premium
Ratings
Optimistic Buy Rating for NeoGenomics Amid CEO Transition and Growth Potential
2M ago
Challenging Growth Outlook and Competitive Pressures Lead to Hold Rating for NeoGenomics
Premium
Ratings
Challenging Growth Outlook and Competitive Pressures Lead to Hold Rating for NeoGenomics
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100